Inoue, Y., Suzuki, H., Hibino, H., Takaya, A., Mikami, K., Yamamoto, K., & Matsumoto, H. (2021). Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia. Brain Behav.
Chicago-stil citatInoue, Yuichi, Hidenobu Suzuki, Hiroyuki Hibino, Atsuhiko Takaya, Katsunaka Mikami, Kenji Yamamoto, och Hideo Matsumoto. "Continuation Rate for Asenapine and Brexpiprazole Treatment in Patients With Schizophrenia." Brain Behav 2021.
MLA-referensInoue, Yuichi, et al. "Continuation Rate for Asenapine and Brexpiprazole Treatment in Patients With Schizophrenia." Brain Behav 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.